Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19
Azita H. Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, Isaac Dreyfus, Hessam Kakavand, Hamid Ariannejad, Aakriti Gupta, Mahesh V. Madhavan, Benjamín Van Tassell, David Jiménez, Manuel Monréal, Muthiah Vaduganathan, John Fanikos, Dave L. Dixon, Gregory Piazza, Sahil A. Parikh, Deepak L. Bhatt, Gregory Y.H. Lip, Gregg W. Stone, Harlan M. Krumholz, Peter Libby, Samuel Z. Goldhaber, Behnood Bikdeli
Topics & Concepts
MedicineFibrateDyslipidemiaRandomized controlled trialCoronavirus disease 2019 (COVID-19)StatinPharmacologyInflammationInternal medicineDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesLipoproteins and Cardiovascular HealthLiver Disease Diagnosis and Treatment